3 Predictions for Post-COVID Clinical Trial Decentralization
HIT Consultant
APRIL 27, 2022
Marc Leighton, VP of Product at Florence Healthcare. Prior to COVID , major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) The power dynamic between sites and sponsors will become more balanced.
Let's personalize your content